Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Citadel Embolization Device Study

NCT: NCT04057352 · ACTIVE_NOT_RECRUITING

NCT IDNCT04057352
StatusACTIVE_NOT_RECRUITING
Start Date2019-07-18
Completion2026-11-15

Brief Summary

The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular's Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.

Frequently Asked Questions

What is Citadel Embolization Device Study?

Citadel Embolization Device Study is a clinical trial registered under NCT04057352. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04057352?

The current status of NCT04057352 (Citadel Embolization Device Study) is: ACTIVE_NOT_RECRUITING.

When did Citadel Embolization Device Study start?

Citadel Embolization Device Study started on 2019-07-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑